Cita APA

Rakovitch, E., Nofech-Mozes, S., Hanna, W., Narod, S., Thiruchelvam, D., Saskin, R., . . . Paszat, L. (2012). HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ. Nature Publishing Group.

Citación estilo Chicago

Rakovitch, E., S. Nofech-Mozes, W. Hanna, S. Narod, D. Thiruchelvam, R. Saskin, J. Spayne, C. Taylor, y L. Paszat. HER2/neu and Ki-67 Expression Predict Non-invasive Recurrence Following Breast-conserving Therapy for Ductal Carcinoma in Situ. Nature Publishing Group, 2012.

Cita MLA

Rakovitch, E., et al. HER2/neu and Ki-67 Expression Predict Non-invasive Recurrence Following Breast-conserving Therapy for Ductal Carcinoma in Situ. Nature Publishing Group, 2012.